From the Division of Plastic and Reconstructive Surgery, Yale-New Haven Hospital, Yale School of Medicine, New Haven, CT.
Mayo Clinic, Alix School of Medicine, Rochester, MN.
Ann Plast Surg. 2024 Jan 1;92(1):100-105. doi: 10.1097/SAP.0000000000003731. Epub 2023 Oct 23.
In the past decade, vascularized composite allotransplantation (VCA) has become clinical reality for reconstruction after face and hand trauma. It offers patients the unique opportunity to regain form and function in a way that had only been achieved with traditional reconstruction or with the use of prostheses. On the other hand, prostheses for facial and hand reconstruction have continued to evolve over the years and, in many cases, represent the primary option for patients after hand and face trauma. We compared the cost, associated complications, and long-term outcomes of VCA with prostheses for reconstruction of the face and hand/upper extremity. Ultimately, VCA and prostheses represent 2 different reconstructive options with distinct benefit profiles and associated limitations and should ideally not be perceived as competing choices. Our work adds a valuable component to the general framework guiding the decision to offer VCA or prostheses for reconstruction after face and upper extremity trauma.
在过去的十年中,血管化复合组织移植(VCA)已成为面部和手部创伤后重建的临床现实。它为患者提供了以传统重建或使用假体无法实现的方式恢复形态和功能的独特机会。另一方面,用于面部和手部重建的假体多年来一直在不断发展,在许多情况下,它们是手部和面部创伤后患者的主要选择。我们比较了 VCA 与假体用于面部和手/上肢重建的成本、相关并发症和长期结果。最终,VCA 和假体代表了 2 种具有不同获益特征和相关局限性的不同重建选择,理想情况下不应将它们视为相互竞争的选择。我们的工作为指导在面部和上肢创伤后提供 VCA 或假体重建的决策的总体框架增加了一个有价值的组成部分。